Alexandria Real Estate Equities
ARE
#2281
Rank
C$11.09 B
Marketcap
C$64.21
Share price
2.61%
Change (1 day)
-54.63%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -C$22.85 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are C$2.97 Billion. In 2024 the company made an earning of C$0.96 Billion, an increase over its 2023 earnings that were of C$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$22.85 Million-102.37%
2024 C$0.96 B96.11%
2023 C$0.49 B-53.56%
2022 C$1.05 B-3.96%
2021 C$1.10 B-20.26%
2020 C$1.38 B72.88%
2019 C$0.79 B3.11%
2018 C$0.77 B73.54%
2017 C$0.44 B464.88%
2016 C$78.97 M-77.32%
2015 C$0.34 B36.31%
2014 C$0.25 B-10.81%
2013 C$0.28 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.37 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.66 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.09 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.37 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.09 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.39 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.18 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA